Under the deal, Globus Medical (NYSE:GMED) will buy all of Nevro's (NVRO) stock for $5.85 per share in cash. The price represents a 27% premium to the 90-day volume-weighted average price of $4.61 ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Globus Medical (GMED – Research Report) and Nevro Corp (NVRO – Research Report). See what stocks are receiving ...

Canaccord raised the firm’s price target on Nevro (NVRO) to $5.85 from $4 and keeps a Hold rating on the shares. The firm noted Globus Medical (GMED) announced today that it had entered into a ...

Nevro (NVRO), another stock in the Zacks Medical ... Should You Invest in Globus Medical, Inc. (GMED)? Before you invest in Globus Medical, Inc. (GMED), want to know the best stocks to buy ...

REDWOOD CITY, Calif., March 4, 2025 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic ...

(NYSE:NVRO) for $250 million. While initially met with investor skepticism, analysts view this deal as potentially neutral to positive for GMED over the next three years. The acquisition is expected ...

NEVRO ($NVRO) is expected to release its quarterly earnings data on Tuesday, March 4th after market close, per Finnhub. Analysts are expecting revenue of $104,594,880 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Nevro Corp. (NVRO) on Tuesday reported a loss of $53.1 million in its fourth quarter. The Redwood City, California-based company said it ...